Provided by Tiger Trade Technology Pte. Ltd.

Novel Coronavirus Treatment

945.017
-3.557-0.37%
Number of Gainers:7
Number of Losers:9
Number of Flat:17
PE:- -
High:952.966
Open:945.695
Low:941.113
Close:948.574
Volume:21.23M
Turnover:229.30M
Market Cap:232.95B
Float Cap:191.09B

Loading ...

ASX Growth Companies With High Insider Ownership You Should Know

Simply Wall St.
·
Sep 02

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Woolworths Group (ASX:WOW) Lifted Profit And Dividends, Is The Stock Fully Valued?

Simply Wall St.
·
Sep 01

CSL's U.S. Agreements Remove Two Stock Overhangs

Dow Jones
·
Sep 01

Genetic Signatures Ltd-Final Director's Interest Notice

THOMSON REUTERS
·
Sep 01

Nanoveu Says US Patent Granted for AI Object Detection Accelerator Circuitry

Reuters
·
Sep 01

ASX Preview: Australian Shares to Fall as Oil Surges on US-Iran Conflict; Ausgold Fiscal 2026 Loss Narrows

MT Newswires Live
·
Sep 01

CSL Secures US Agreements to Cut Medicine Costs, Expand Manufacturing

MT Newswires Live
·
Sep 01

CSL Signs U.S. Government Agreements to Lower Drug Prices for Medicaid

Reuters
·
Sep 01

CSL Limited-Agreements with U.S. on Drug Prices and Manufacturing

THOMSON REUTERS
·
Sep 01

Nanoveu Ltd-US Patent Granted for Ecs-Dot Object Detection Technology

THOMSON REUTERS
·
Sep 01

Coles (ASX:COL) Boosts Fully Franked Dividend While Eyeing Pet Retail Deals – What Is The Capital Allocation Signal?

Simply Wall St.
·
Sep 01

CSL Ltd: Agreements Support Lower Prices for CSL Therapies and Reflect CSL's $1.5 Billion Plan to Expand Its U.S. Manufacturing Capacity in Illinois

THOMSON REUTERS
·
Sep 01

CSL Enters Agreements with the U.S. Government to Lower Drug Prices and Support Investment in U.S. Manufacturing

THOMSON REUTERS
·
Sep 01

CSL : Agreements Provide CSL with Additional Certainty Regarding Exposure to U.S. Drug Pricing & Certain Section 232 Tariffs

THOMSON REUTERS
·
Sep 01

CSL : Entered into Onshoring Agreement with the U.S. Department of Commerce

THOMSON REUTERS
·
Sep 01

CSL : Project to Substantially Increase Co's Ability to Produce Immunoglobulins & Albumin for People with Rare Diseases & Serious Conditions

THOMSON REUTERS
·
Sep 01

CSL Ltd: Project is Expected to Create at Least 300 New Pharmaceutical Manufacturing Jobs and Approximately 800 Construction and Related Jobs

THOMSON REUTERS
·
Sep 01

CSL : Does not Anticipate Any Material Impact During Fiscal Year 2027

THOMSON REUTERS
·
Sep 01

ASX Growth Companies With High Insider Ownership

Simply Wall St.
·
Sep 01